References
Ferme C, Eghbali H, Meerwaldt JH et al (2007) Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med 357:1916–1927
Allemani C, Sant M, De Angelis R, Marcos-Gragera R, Coebergh JW (2006) Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 107:352–360
Moser EC, Noordijk EM, van Leeuwen FE et al (2006) Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107:2912–2919
Galper SL, Yu JB, Mauch PM et al (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:412–418
Machann W, Beer M, Breunig M et al (2011) Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin’s disease. Int J Radiat Oncol Biol Phys 79:1117–1123
Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831–2837
Lund MB, Ihlen H, Voss BM et al (1996) Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin’s disease: an echocardiographic study. Heart 75:591–595
Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67:10–18
Heidenreich PA, Schnittger I, Strauss HW et al (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol 25:43–49
Hodgson DC (2011) Late effects in the era of modern therapy for Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2011:323–329
Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339:21–26
Wilder RB, Rodriguez MA, Tucker SL et al (2001) Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys 50:743–749
Alm El-Din MA, El-Badawy SA, Taghian AG (2008) Breast cancer after treatment of Hodgkin’s lymphoma: general review. Int J Radiat Oncol Biol Phys 72:1291–1297
Lauk S, Trott KR (1988) Radiation induced heart disease in hypertensive rats. Int J Radiat Oncol Biol Phys 14:109–114
Stewart FA, Heeneman S, Te Poele J et al (2006) Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 168:649–658
Darby SC, Cutter DJ, Boerma M et al (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76:656–665
Kim WH, Lee BK, Lee S et al (2010) Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study. Clin Res Cardiol 99:639–644
Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109:1878–1886
Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P (1998) Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol 46:51–62
Rademaker J, Schoder H, Ariaratnam NS et al (2008) Coronary artery disease after radiation therapy for Hodgkin’s lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. Am J Roentgenol 191:32–37
Andersen R, Wethal T, Gunther A et al (2010) Relation of coronary artery calcium score to premature coronary artery disease in survivors > 15 years of Hodgkin’s lymphoma. Am J Cardiol 105:149–152
Kupeli S, Hazirolan T, Varan A et al (2010) Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin’s lymphoma. J Clin Oncol 28:1025–1030
Templin C, Ghadri JR, Wyss C, Luscher TF, Kaufmann P, Landmesser U (2010) Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy. Clin Res Cardiol 99:199–201
Biondi-Zoccai GG, Giraudi E, Moretti C et al (2010) Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol 99:235–242
Rittger H, Rieber J, Kogler K et al (2011) Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol 100:439–446
Schachinger V, Herdeg C, Scheller B (2010) Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! Clin Res Cardiol 99:531–539
Merkle N, Wohrle J, Nusser T et al (2010) Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease. Clin Res Cardiol 99:21–28
Prosnitz RG, Hubbs JL, Evans ES et al (2007) Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment. Cancer 110:1840–1850
Lee DC, Simonetti OP, Harris KR et al (2004) Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 110:58–65
Korosoglou G, Mueller D, Lehrke S et al (2010) Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol 20:1841–1850
Hosch W, Heye T, Schulz F et al (2011) Image quality and radiation dose in 256-slice cardiac computed tomography: comparison of prospective versus retrospective image acquisition protocols. Eur J Radiol 80:127–135
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Korosoglou, G., Kristen, A.V., Andrassy, M. et al. Severe left main coronary stenosis in a young female patient, 6 years after mediastinal radiation therapy for non-Hodgkin lymphoma: assessment by coronary angiography and intravascular ultrasound. Clin Res Cardiol 101, 317–320 (2012). https://doi.org/10.1007/s00392-012-0413-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-012-0413-9